本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Carisma Therapeutics

0.4019
+0.081925.59%
盤後0.3741-0.0278-6.92%19:59 EDT
成交量:711.74萬
成交額:262.11萬
市值:1,679.46萬
市盈率:-0.34
高:0.4309
開:0.3139
低:0.3000
收:0.3200
52周最高:1.27
52周最低:0.1417
股本:4,178.81萬
流通股本:3,125.58萬
量比:0.07
換手率:22.77%
股息:- -
股息率:- -
每股收益(TTM):-1.1834
每股收益(LYR):-1.4588
淨資產收益率:-362.79%
總資產收益率:-85.68%
市淨率:-0.37
市盈率(LYR):-0.28

資料載入中...

2025/08/29

重要事件披露

Form 8-K - Current report
2025/08/29

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/08/08

重要事件披露

Form 8-K - Current report
2025/08/08

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/15

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/07/15

重要事件披露

Form 8-K - Current report
2025/06/25

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/06/23

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/06/23

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/06/23

重要事件披露

Form 8-K - Current report
2025/06/23

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2025/06/12

重要事件披露

Form 8-K - Current report
2025/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/30

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/04/16

重要事件披露

Form 8-K - Current report
2025/03/31

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/31

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/10

重要事件披露

Form 8-K - Current report